1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Motherisk Update 2014
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting,
Details to be announced
- Read more in our News Archive
Current Studies at Motherisk
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Current Studies at Motherisk: Folic Acid Before and During Pregnancy
The Motherisk Program, located at The Hospital for Sick Children, invites women between the ages of 18 and 45 to participate in a study on folic acid during pregnancy.
We are looking for healthy women who are either planning a pregnancy or who are less than 6 weeks pregnant, but are not currently taking folic acid or multivitamins.
Motherisk will provide multivitamins containing folic acid to all participants upon study inclusion and until 30 weeks of gestation. These multivitamins are to be taken daily. They are approved by Health Canada and can be safely obtained from healthcare professionals and healthcare services.
Researchers at The Hospital for Sick Children will draw blood samples at four times during the study to measure folate levels. Folate measurements will take place at The Hospital for Sick Children (Toronto, Ontario); therefore, study participation may be most convenient for women residing in the GTA.
Participants will be paid $250 (maximum) upon completion of the study. Payments may be adjusted depending on the degree of participation.
If you would like to participate or would like more information, please contact the study coordinator, Mahvash Shere, at (416) 813-7283 or by e-mail at firstname.lastname@example.org